The number of Iran’s daily COVID-19 deaths and infections witnessed a decrease during the 24-hour period to Friday, according to the latest Health Ministry figures.
The ministry announced in a Friday statement that the country’s daily COVID-19 deaths and infections stood at 445 and 21,114, respectively, in the past 24 hours.
The figures were 505 and 26,821 during its preceding 24 hours.
The statement added the total COVID-19 death toll and infections since the beginning of the outbreak in the country in late February 2020 stand at 112,935 and 5,237,799, respectively.
It added that 7,486 COVID-19 patients are in critical condition, and of the newly-detected cases, 3,638 individuals have been hospitalized.
The ministry said 4,481,814 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
The statement added 30,017,378 coronavirus diagnostic tests have so far been carried out in the country and 32,409,627 doses of COVID-19 vaccines have been administered, of which 958,933 pertain to the 24-hour period to Friday.
The Health Ministry said 246 cities in the country are coded red (very high-risk), while 144 are in the orange zone (high-risk).
The number of the country’s yellow (medium-risk) cities is 58, according to the ministry.
Iran has been grappling with a fifth wave of the COVID-19 pandemic since a few weeks ago, mainly sparked by the spread of the Indian coronavirus variant, known as Delta, seeing a resurgence in deaths and infections.
The country’s public vaccination process has gained greater momentum over the past few weeks in view of the rise in imports and domestic production.
Iran has received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN), and has also developed a number of COVID jabs domestically.
According to figures by the Islamic Republic of Iran Customs Administration (IRICA), Iran has so far imported over 46.6 million doses of COVID-19 vaccines, with China’s Sinopharm accounting for the biggest share (37,529,596 doses) of the purchases.